Therapy Areas: Infectious Diseases
Symbiomix Therapeutics Receives FDA Approval for Solosec (secnidazole) Oral Granules for Treatment of Bacterial Vaginosis in Adult Women
19 September 2017 - - US-based biopharmaceutical company Symbiomix Therapeutics has received US Food and Drug Administration (FDA) approval for Solosec (secnidazole) 2g oral granules for the treatment...
Phosphorus Adds Ophthalmologic and Pharmacogenomic Tests
15 September 2017 - - New York, New York-based computational genomics company Phosphorus has expanded its catalogue with the addition of an ophthalmologic test for inherited conditions associated...
Bavarian Nordic to discontinue Phase 3 Study of PROSTVAC in metastatic prostate cancer
15 September 2017 - Integrated biotechnology company Bavarian Nordic A/S (CPH:BAVA)(OTC: BVNRY) announced on Thursday that an independent Data Monitoring Committee (DMCB) has determined, based on a pr...
Geom Therapeutics, NIAID Partner to Conduct Study of Novel Cephalosporin Antibiotic
14 September 2017 - - US-based antibiotic developer Geom Therapeutics, Inc. has signed a clinical trial agreement with the National Institute of Allergy and Infectious Diseases (NIAID), part of the Na...
Cancer Prevention Pharmaceuticals Receives USD 9.5m in Additional Funding from Sucampo Following Phase 3 Trial Progress
13 September 2017 - - US-based biotech company Cancer Prevention Pharmaceuticals, Inc has received a total of USD 9.5m from its North America commercialization partner Sucampo Pharmaceuticals, Inc. (N...
Global Biopharmaceutical Contract Manufacturing Market to Reach USD 15,467.8m by 2027, Future Market Insights Forecasts
13 September 2017 - - The global biopharmaceutical contract manufacturing market is estimated to be valued at USD 5,625m by the end of 2017 and this is expected to increase to USD 15,467.8m ...